146 related articles for article (PubMed ID: 17579620)
21. Synthesis, X-ray crystallographic, and NMR characterizations of platinum(II) and platinum(IV) pyrophosphato complexes.
Mishur RJ; Zheng C; Gilbert TM; Bose RN
Inorg Chem; 2008 Sep; 47(18):7972-82. PubMed ID: 18693681
[TBL] [Abstract][Full Text] [Related]
22. Reactivity of ammonia ligands of the antitumor agent cisplatin: a unique dodecanuclear Pt4,Pd4,Ag4 platform for four cytosine model nucleobases.
Kampf G; Sanz Miguel PJ; Morell Cerdà M; Willermann M; Schneider A; Lippert B
Chemistry; 2008; 14(23):6882-91. PubMed ID: 18576415
[TBL] [Abstract][Full Text] [Related]
23. Cellular accumulation and DNA platination of two new platinum(II) anticancer compounds based on anthracene derivatives as carrier ligands.
Marqués-Gallego P; Kalayda GV; Jaehde U; Dulk Hd; Brouwer J; Reedijk J
J Inorg Biochem; 2009 May; 103(5):791-6. PubMed ID: 19303143
[TBL] [Abstract][Full Text] [Related]
24. Side-on binding of p-sulphonatocalix[4]arene to the dinuclear platinum complex trans-[{PtCl(NH3)2}2mu-dpzm]2+ and its implications for anticancer drug delivery.
Wheate NJ; Abbott GM; Tate RJ; Clements CJ; Edrada-Ebel R; Johnston BF
J Inorg Biochem; 2009 Mar; 103(3):448-54. PubMed ID: 19171382
[TBL] [Abstract][Full Text] [Related]
25. Energetics, conformation, and recognition of DNA duplexes modified by methylated analogues of [PtCl(dien)]+.
Nováková O; Malina J; Kaspárková J; Halámiková A; Bernard V; Intini F; Natile G; Brabec V
Chemistry; 2009 Jun; 15(25):6211-21. PubMed ID: 19449361
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, structures and in vitro cytotoxicity of some platinum(II) complexes containing thiocarbamate esters.
Dolfen D; Schottler K; Valiahdi SM; Jakupec MA; Keppler BK; Tiekink ER; Mohr F
J Inorg Biochem; 2008 Dec; 102(12):2067-71. PubMed ID: 18707761
[TBL] [Abstract][Full Text] [Related]
27. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
[TBL] [Abstract][Full Text] [Related]
28. XANES determination of the platinum oxidation state distribution in cancer cells treated with platinum(IV) anticancer agents.
Hall MD; Foran GJ; Zhang M; Beale PJ; Hambley TW
J Am Chem Soc; 2003 Jun; 125(25):7524-5. PubMed ID: 12812486
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, crystal structure, studies in solution and cytotoxicity of two new fluorescent platinum(II) compounds containing anthracene derivatives as a carrier ligand.
Marqués-Gallego P; den Dulk H; Brouwer J; Kooijman H; Spek AL; Roubeau O; Teat SJ; Reedijk J
Inorg Chem; 2008 Dec; 47(23):11171-9. PubMed ID: 18975941
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and characterisation of mixed ligand Pt(II) and Pt(IV) oxadiazoline complexes.
Sarju J; Arbour J; Sayer J; Rohrmoser B; Scherer W; Wagner G
Dalton Trans; 2008 Oct; (39):5302-12. PubMed ID: 18827937
[TBL] [Abstract][Full Text] [Related]
31. Structure and dynamics of methyl cis-3,4-diamino-2,3,4,6-tetradeoxy-alpha-L-lyxo-hexopyranoside complexes with PtCl(2) and PdCl(2), by (1)H, (2)H, (13)C, (15)N and (195)Pt NMR spectroscopy in DMSO, CD(3)CN and H(2)O.
Bednarek E; Sitkowski J; Kawecki R; Kozerski L; Bocian W; Pazderski L; Priebe W
Dalton Trans; 2008 Aug; (31):4129-37. PubMed ID: 18688431
[TBL] [Abstract][Full Text] [Related]
32. Solution behaviour and biomolecular interactions of two cytotoxic trans-platinum(II) complexes bearing aliphatic amine ligands.
Cubo L; Casini A; Gabbiani C; Mastrobuoni G; Messori L; Jiménez-Barbero J; Navarro-Ranninger C; Quiroga AG
Chemistry; 2009 Sep; 15(36):9139-46. PubMed ID: 19655350
[TBL] [Abstract][Full Text] [Related]
33. In vivo distribution studies of radioactively labelled platinum complexes; cis-dichlorodiammine platinum(II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum(IV), cis-dichloro-bis-cyclopropylamine platinum(II), and cis-diammine 1,1-cyclobutanedicarboxylate platinum(II) in patients with malignant disease, using a gamma camera.
Owens SE; Thatcher N; Sharma H; Adam N; Harrison R; Smith A; Zaki A; Baer JC; McAuliffe CA; Crowther D
Cancer Chemother Pharmacol; 1985; 14(3):253-7. PubMed ID: 3888431
[TBL] [Abstract][Full Text] [Related]
34. Studies of the mechanism of action of platinum(II) complexes with potent cytotoxicity in human cancer cells.
Krause-Heuer AM; Grünert R; Kühne S; Buczkowska M; Wheate NJ; Le Pevelen DD; Boag LR; Fisher DM; Kasparkova J; Malina J; Bednarski PJ; Brabec V; Aldrich-Wright JR
J Med Chem; 2009 Sep; 52(17):5474-84. PubMed ID: 19658404
[TBL] [Abstract][Full Text] [Related]
35. Towards the rational design of platinum(II) and gold(III) complexes as antitumour agents.
Wang X; Guo Z
Dalton Trans; 2008 Mar; (12):1521-32. PubMed ID: 18335133
[TBL] [Abstract][Full Text] [Related]
36. Study by HPLC-MS of the interaction of platinum antitumor complexes with potato carboxypeptidase inhibitor (PCI).
Martínez A; Moreno V; Sanglas L; de Llorens R; Avilés FX; Lorenzo J
Bioorg Med Chem; 2008 Jul; 16(14):6832-40. PubMed ID: 18554917
[TBL] [Abstract][Full Text] [Related]
37. The fate of platinum(II) and platinum(IV) anti-cancer agents in cancer cells and tumours.
Hall MD; Alderden RA; Zhang M; Beale PJ; Cai Z; Lai B; Stampfl AP; Hambley TW
J Struct Biol; 2006 Jul; 155(1):38-44. PubMed ID: 16630726
[TBL] [Abstract][Full Text] [Related]
38. Drug penetration in solid tumours.
Minchinton AI; Tannock IF
Nat Rev Cancer; 2006 Aug; 6(8):583-92. PubMed ID: 16862189
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and cytotoxicity of platinum(II) complexes of a physiologically active carrier histamine.
Chen XZ; Ye QS; Lou LG; Xie MJ; Liu WP; Yu Y; Hou SQ
Arch Pharm (Weinheim); 2008 Feb; 341(2):132-6. PubMed ID: 18186542
[TBL] [Abstract][Full Text] [Related]
40. Antitumor activity of platinum(II) complexes with histamine and radioiodinated histamine in a transplantable murine adenocarcinoma model.
Garnuszek P; Karczmarczyk U; Maurin M
Nucl Med Biol; 2008 Jul; 35(5):605-13. PubMed ID: 18589305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
